Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of VVZ-149 for Postoperative Pain Following Bunionectomy
NCT04430088Phase 3Unknown
- Sponsor
- Vivozon
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of opiranserin in postoperative pain, sponsored by Vivozon. Status: unknown.
02
Drugs
opiranserin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04430088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04430088.